Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

United Therapeutics Corporation (UTHR)

  • Business News
  • Nov. 14, 2025, 20:07 UTC
  • 8
  • 0 comments

UTHR: Notification

Market reaction Comment Full text

Sarepta Therapeutics Inc (SRPT)

  • Business News
  • Nov. 14, 2025, 19:54 UTC
  • 24
  • 1 comments

Sarepta Announces FDA’s Approval of Updated ELEVIDYS Prescribing Information

Market reaction Comment Full text

Retractable Technologies Inc (RVP)

  • Business News
  • Nov. 14, 2025, 19:49 UTC
  • 8
  • 0 comments

Retractable Technologies, Inc. Receives Innovative Technology Designation from Vizient for EasyPoint Blood Collection Tube Holder with Needle

Market reaction Comment Full text

Smart for Life, Inc. (SMFL)

  • Business News
  • Nov. 14, 2025, 19:35 UTC
  • 19
  • 1 comments

Why Your Technical Skills Aren’t Enough for the Next Level

Market reaction Comment Full text

Celyad Oncology SA (CYADY)

  • Business News
  • Nov. 14, 2025, 18:00 UTC
  • 25
  • 1 comments

Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)

Market reaction Comment Full text

Inspire Medical Systems Inc. (INSP)

  • Business News
  • Nov. 14, 2025, 17:06 UTC
  • 18
  • 1 comments

Law Offices of Frank R. Cruz Encourages Inspire Medical Systems, Inc. (INSP) Shareholders to Inquire About Securities Fraud Class Action

Market reaction Comment Full text

MoonLake Immunotherapeutics (MLTX)

  • Business News
  • Nov. 14, 2025, 17:00 UTC
  • 17
  • 1 comments

MoonLake Immunotherapeutics (MLTX) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

Market reaction Comment Full text

Inspire Medical Systems Inc. (INSP)

  • Business News
  • Nov. 14, 2025, 17:00 UTC
  • 17
  • 1 comments

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm Encourages Inspire Medical Systems, Inc. (INSP) Shareholders To Inquire About Securities Fraud Class Action

Market reaction Comment Full text

Cordlife Group Limited (P8A)

  • Business News
  • Nov. 14, 2025, 16:47 UTC
  • 13
  • 1 comments

Cordlife Reports 9M2025 Revenue Of S$29.4 Million; Focuses On Regulatory Compliance And Operational Recovery

Market reaction Comment Full text

Cordlife Group Limited (P8A)

  • Business News
  • Nov. 14, 2025, 16:47 UTC
  • 21
  • 1 comments

Replace - Financial Statements and Related Announcement :: Third Quarter Results

Market reaction Comment Full text
  • Previous
  • 602
  • 603
  • 604
  • 605
  • 606
  • Next

Search

News categories

  • Technical Exchange News(10945)
  • Event(2382)
  • SEC News(191988)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(125322)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin